Literature DB >> 11229365

Detection of thioredoxin in gastric cancer: association with histological type.

N Noda1, A Ochiai, K Miyazaki, T Sugimura, M Terada, H Wakasugi.   

Abstract

Thioredoxin (TRX) is a redox-active protein with multiple intra- and extracellular functions. This protein exists ubiquitously in all life forms, from primitive living cells, such as Escherichia coli and yeast, to higher mammals. Recently, augmentation of the expression and transcription level of TRX has been reported in tumors of various organs. In this study, we examined the expression of TRX in gastric cancer with respect to its histological type and depth of invasion. The association with cell proliferation was also studied. Results of histochemical analysis of surgical specimens as well as cytochemical analysis and Northern blot analysis of gastric cancer cell lines indicated that TRX is predominantly expressed in undifferentiated type gastric cancer rather than in the differentiated type. Neither the depth of tumor invasion nor cell proliferation significantly determined the staining intensity for TRX.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11229365     DOI: 10.1089/15230860050192297

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  3 in total

1.  Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction.

Authors:  Akram Sadeghirizi; Razieh Yazdanparast; Safiyeh Aghazadeh
Journal:  Tumour Biol       Date:  2015-12-10

2.  Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma.

Authors:  Caroline M Woolston; Srinivasan Madhusudan; Irshad N Soomro; Dileep N Lobo; Alexander M Reece-Smith; Simon L Parsons; Stewart G Martin
Journal:  Redox Biol       Date:  2013-05-23       Impact factor: 11.799

3.  Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer.

Authors:  Wenjing Shang; Zhongdong Xie; Fengying Lu; Daoquan Fang; Tianbin Tang; Ruichun Bi; Lingli Chen; Lei Jiang
Journal:  Oxid Med Cell Longev       Date:  2019-02-18       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.